Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11919957 Methods of treating tumor

Patent 11919957 was granted and assigned to Bristol-Myers Squibb Company on March, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
0
Date Filed
October 17, 2022
0
Date of Patent
March 5, 2024
0
Patent Applicant
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
0
Patent Application Number
18047216
0
Patent Citations
‌
US Patent 7214493 Polynucleotides encoding humanized antibodies against human 4-1BB
0
‌
US Patent 7288638 Fully human antibodies against human 4-1BB
0
‌
US Patent 7488802 Antibodies against PD-1
0
‌
US Patent 7595048 Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1
0
‌
US Patent 7767429 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
0
‌
US Patent 6887673 Humanized antibodies against human 4-1BB
0
‌
US Patent 6905685 Methods of using antibodies to human receptor protein 4-1BB
0
‌
US Patent 6974863 Antibody for 4-1BB
0
‌
US Patent 6984720 Human CTLA-4 antibodies
0
‌
US Patent 7034121 Antibodies against CTLA4
0
•••
Patent Inventor Names
Han Chang
0
Prabhu Seshaiyer Bhagavatheeswaran
0
William J. Geese
0
Giovanni Selvaggi
0
Joseph Daniel Szustakowski
0
Nicholas Allan John Botwood
0
Sabine Maier
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11919957
0
Patent Primary Examiner
‌
Sean E Aeder
0
CPC Code
‌
C07K 16/2818
0

Find more entities like US Patent 11919957 Methods of treating tumor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo